Abstract
Background: Oral squamous cell carcinoma (OSCC) has been the sixth most common cancer worldwide. Emerging studies showed long non-coding RNAs to play a key role in human cancers. However, the molecular mechanisms underlying the initiation and progression of OSCC remained to be further explored.
Objective: The present study aimed to identify differentially expressed lncRNAs and mRNAs in OSCC.
Methods: GSE30784 was analyzed to identify differentially expressed lncRNAs and mRNAs in OSCC. Protein-protein interaction network and co-expression network analyses were performed to reveal the potential roles of OSCC related mRNAs and lncRNAs.
Results: In the present study, we identified 21 up-regulated lncRNAs and 54 down-regulated lncRNAs in OSCC progression. Next, we constructed a lncRNA related co-expression network in OSCC, which included 692 mRNAs and 2193 edges. Bioinformatics analysis showed that lncRNAs were widely co-expressed with regulating type I interferon signaling pathway, extracellular matrix organization, collagen catabolic process, immune response, ECM-receptor interaction, Focal adhesion, and PI3K-Akt signaling pathway. A key network, including lncRNA C5orf66-AS1, C21orf15, LOC100506098, PCBP1-AS1, LOC284825, OR7E14P, HCG22, and FLG-AS1, was found to be involved in the regulation of immune response to tumor cell, Golgi calcium ion transport, negative regulation of vitamin D receptor signaling pathway, and glycerol- 3-phosphate catabolic process. Moreover, we found higher expressions of CYP4F29P, PCBP1- AS1, HCG22, and C5orf66-AS1, which were associated with shorter overall survival time in OSCC samples.
Conclusions: Our analysis can provide novel insights to explore the potential mechanisms underlying OSCC progression.
Keywords: Long non-coding RNAs, oral squamous cell carcinoma, protein-protein interaction analysis, co-expression analysis, biomarker, mRNAs.
Graphical Abstract
[http://dx.doi.org/10.1038/nature14129] [PMID: 25631445]
[http://dx.doi.org/10.1158/1078-0432.CCR-14-0205] [PMID: 24668645]
[http://dx.doi.org/10.1093/nar/gkv1528] [PMID: 26743006]
[http://dx.doi.org/10.1016/j.cell.2017.11.040]
[http://dx.doi.org/10.1126/science.1111444] [PMID: 16141061]
[http://dx.doi.org/10.1186/1741-7007-11-59] [PMID: 23721193]
[http://dx.doi.org/10.1186/s12943-017-0679-7] [PMID: 28651607]
[http://dx.doi.org/10.1111/j.1742-4658.2012.08694.x] [PMID: 22776265]
[http://dx.doi.org/10.2174/1381612825666190830161528] [PMID: 31470781]
[http://dx.doi.org/10.18632/oncotarget.17272] [PMID: 28938580]
[PMID: 28979812]
[http://dx.doi.org/10.1002/jcp.26185] [PMID: 28926115]
[http://dx.doi.org/10.3892/br.2017.876] [PMID: 28413645]
[http://dx.doi.org/10.1111/jop.12769] [PMID: 30053324]
[http://dx.doi.org/10.18632/oncotarget.23452] [PMID: 29416684]
[http://dx.doi.org/10.1158/1055-9965.EPI-07-2893] [PMID: 18669583]
[http://dx.doi.org/10.1016/j.nbd.2012.06.004] [PMID: 22709987]
[http://dx.doi.org/10.1093/nar/gkn923] [PMID: 19033363]
[http://dx.doi.org/10.1093/nar/gkq973] [PMID: 21045058]
[http://dx.doi.org/10.1186/1471-2105-4-2] [PMID: 12525261]
[http://dx.doi.org/10.3233/CBM-160166] [PMID: 28211799]
[http://dx.doi.org/10.1016/j.biopha.2018.01.164] [PMID: 29710493]
[http://dx.doi.org/10.3727/096504018X15185714083446] [PMID: 29523226]
[http://dx.doi.org/10.3892/ol.2017.6886] [PMID: 29113184]
[PMID: 28045101]
[http://dx.doi.org/10.1159/000492883] [PMID: 30138934]
[http://dx.doi.org/10.1016/j.bbrc.2018.08.077] [PMID: 30135013]
[http://dx.doi.org/10.1016/j.compbiolchem.2018.11.008] [PMID: 30476706]
[http://dx.doi.org/10.7717/peerj.5307] [PMID: 30128179]
[http://dx.doi.org/10.2174/0929867043364667] [PMID: 15279552]
[http://dx.doi.org/10.1093/nar/gkv458] [PMID: 25958395]
[http://dx.doi.org/10.1016/j.ab.2012.03.015] [PMID: 22459120]
[http://dx.doi.org/10.1186/s13048-019-0558-5] [PMID: 31481095]
[http://dx.doi.org/10.1038/srep42421] [PMID: 28176861]
[http://dx.doi.org/10.1016/j.critrevonc.2019.102854] [PMID: 31877535]
[http://dx.doi.org/10.1002/jcp.27755] [PMID: 30565679]
[PMID: 30091006]
[http://dx.doi.org/10.3892/ol.2018.9143] [PMID: 30127984]
[PMID: 30074401]